1/21/2022 Trends in health service use for Canadian adults with dementia and Parkinson disease during the first wave of the COVID-19 pandemic Bronskill SE, Maclagan LC, Maxwell CJ, Iaboni A, Jaakkimainen RL, Marras C, Wang X, Guan J, Harris DA, Emdin A, Jones A, Sourial N, Godard-Sebillotte C, Vedel I, Austin PC, Swartz RH. JAMA Health Forum. 2022; 3(1):e214599. Epub 2022 Jan 21. DOI: https://doi.org/10.1001/jamahealthforum.2021.4599
7/9/2021 Exposure to phosphoglycerate kinase 1 activators and incidence of Parkinson’s disease Gros P, Wang X, Guan J, Lang AE, Austin PC, Welk B, Visanji NP, Marras C. Mov Disord. 2021; 36(10):2419-25. Epub 2021 Jul 9. DOI: https://doi.org/10.1002/mds.28712
8/28/2020 Survival and health care use after deep brain stimulation for Parkinson’s Disease Crispo JAG, Lam M, Le B, Shariff SZ, Ansell DR, Squarzolo M, Ouellette D, Thibault DP, Marras C, Willis AW, Seitz D. Can J Neurol Sci. 2021; 48(3):372-82. Epub 2020 Aug 28. DOI: https://doi.org/10.1017/cjn.2020.187